Saturday, January 14, 2017 2:43:28 PM
I suspect we're seeing investors trying to get in on the MJ sector and finding a company with zero debt, toxic or otherwise, with its first profitable quarter and promising another record quarter, and a CEO who's paid back 50 million shares to the treasury. That combined with the fact that there's been minimal dilution despite all your claims to the contrary and a relatively low float has created more share demand than supply.
It's been two years since we've been at these levels so there are not a lot of folks left who bought shares here. Most would have already sold out by now. There's little selling pressure and a lot of folks who want in. TRTC peaked at $.7455 in April with a lot less sector demand before pulling back under $.30. Who knows where this will peak. However, I agree that the actual value, until we get any further revenue news, is probably closer to $.30. I view $.25 to $.30 as a floor/base granting a premium for it being in the MJ sector. On the other hand, how many MJ stocks are trading at their actual value?
Les
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM